BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19309299)

  • 1. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.
    Eller-Vainicher C; Chiodini I; Battista C; Viti R; Mascia ML; Massironi S; Peracchi M; D'Agruma L; Minisola S; Corbetta S; Cole DE; Spada A; Scillitani A
    J Bone Miner Res; 2009 Aug; 24(8):1404-10. PubMed ID: 19309299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
    Lourenço DM; Coutinho FL; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
    J Bone Miner Res; 2010 Nov; 25(11):2382-91. PubMed ID: 20499354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
    Coutinho FL; Lourenço DM; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):462-8. PubMed ID: 19650788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
    Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
    World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment?
    Sneider MS; Solorzano CC; Montano RE; Anello C; Irvin GL; Lew JI
    J Surg Res; 2009 Jul; 155(1):100-3. PubMed ID: 19135685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
    Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
    Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of smoking on severity of disease in primary hyperparathyroidism.
    Amstrup AK; Rejnmark L; Vestergaard P; Heickendorff L; Mosekilde L
    Calcif Tissue Int; 2010 Nov; 87(5):406-13. PubMed ID: 20862465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
    Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
    Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
    Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
    Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.
    Gianotti L; Tassone F; Cesario F; Pia A; Razzore P; Magro G; Piovesan A; Borretta G
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
    Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study on incidence of primary hyperparathyroidism in patients with goiter].
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Pol Merkur Lekarski; 2006 Nov; 21(125):469-73. PubMed ID: 17345842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery.
    Kandil E; Alabbas H; Tufaro AP; Carson KA; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):147-50. PubMed ID: 20157060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.
    Twigt BA; Scholten A; Valk GD; Rinkes IH; Vriens MR
    Orphanet J Rare Dis; 2013 Apr; 8():50. PubMed ID: 23547958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of primary hyperparathyroidism in Europe.
    Adami S; Marcocci C; Gatti D
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N18-23. PubMed ID: 12412773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.